BRD2 and oligospermia: Research indicates that male pediatric cancer patients who undergo treatment regimens including busulfan often experience reduced testicular volume, significantly elevated FSH levels, and a high incidence of oligospermia or azoospermia in adulthood (Cattoni et al., 2023).